Biosynth

News

Lilly and insitro team up to develop AI-powered siRNA metabolic drugs

Eli Lilly and insitro said the deals offers a “new paradigm” for collaborations between major pharmaceutical companies and smaller biotechs.

Jenna Philpott

News

Suven Pharmaceuticals to gain controlling stake in Sapala Organics

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Lilly and insitro team up to develop AI-powered siRNA metabolic drugs

Suven Pharmaceuticals to gain controlling stake in Sapala Organics

Leading Sales and Marketing Intent Data, Database and Data Enrichment Providers and Technology Solutions for the Pharmaceutical Industry

Leading Sales and Marketing Intelligence Providers and Technology Solutions for the Pharmaceutical Industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief